Skip to search formSkip to main contentSkip to account menu

GTX Regimen

Known as: Gemcitabine-Taxotere-Xeloda Regimen 
A regimen consisting of gemcitabine, docetaxel and capecitabine used for the treatment of pancreatic cancer.
National Institutes of Health

Related topics

Related topics

4 relations
Gemcitabine hydrochloridePancreatic carcinomacapecitabinedocetaxel

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Bazı Ormangülü Ballarının Fenolik İçerik Kompozisyonu
Ormangulu bali, ulkemiz cografyasinda ozellikle Karadeniz Bolgesi kiyi kesimlerinde yayilim gosteren Rhododendron bitki… 
2015
2015
Abstract B97: A phase II trial of low-dose multiagent chemotherapy with gemcitabine, taxotere, xeloda, and cisplatin (GTX-C) in subjects with metastatic pancreatic cancer
Background: Triplet chemotherapy has been shown to delay the emergence of resistance and extend survival in patients with… 
2014
2014
A phase II trial of low-dose multiagent chemotherapy with gemcitabine, docetaxel, capecitabine, and cisplatin (GTX-C) in patients with metastatic pancreatic cancer.
213 Background: Multiagent chemotherapy with three agents has been shown to delay the emergence of resistance and extend survival… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)